Abbreviation Definition
|
ABN |
ABNORMAL |
|
A/G |
ALBUMIN/GLOBULIN RATIO |
|
ADE |
ADVERSE DRUG EXPERIENCE |
|
ADM |
ADMINISTRATION |
|
ALK PHOS |
ALKALINE PHOSPHATASE |
|
ALT |
ALANINE AMINOTRANSFERASE |
|
ANESTH |
ANESTHESIA; ANESTHETIC |
|
APP |
APPLICATION |
|
AST |
ASPARTITIE AMINOTRANSFERASE |
|
BANDS |
NEUTROPHILS (BANDS) |
|
BASOS |
BASOPHILS |
|
BLD |
BLOOD OUTSIDE THE VASCULAR SYSTEM (E.G., HEMORRHAGE OR BLOOD USED IN TESTS) |
|
BSP |
BROMSULPHALEIN |
|
BUN |
BLOOD UREA NITROGEN |
|
CA |
CALCIUM |
|
CHE |
CHOLINESTERASE |
|
CM |
CLINICAL MANIFESTATION (SIGN) |
|
CMP |
CONCOMITANT MEDICAL PROBLEM |
|
CMT |
CALIFORNIA MASTITIS TEST |
|
CNS |
CENTRAL NERVOUS SYSTEM |
|
CO2 |
CARBON DIOXIDE |
|
CPK |
CREATINE PHOSPHOKINASE |
|
CPR |
CARDIOPULMONARY RESUSCITATION |
|
CSF |
CEREBROSPINAL FLUID |
|
CTX |
CONCOMITANT TREATMENT |
|
DD |
NUMBER OF DEAD ANIMALS |
|
DDX |
DIFFERENTIAL DIAGNOSIS |
|
DECHALL |
THE EFFECT AFTER DISCONTINUING DRUG USE |
|
DIC |
DISSEMINATED INTRAVASCULAR COAGULATION |
|
DIR |
DIRECT; CONJUGATED |
|
DX |
DIAGNOSIS |
|
DZ |
DISEASE |
|
ELU |
EXTRA LABEL USE OF THE DRUG |
|
EOS |
EOSINOPHILS |
|
FE |
IRON |
|
F/U |
FOLLOW-UP REPORT |
|
GGT |
GAMMA GLUTAMYL TRANSFERASE |
|
GI |
GASTROINTESTINAL |
|
HCO3 |
BICARBONATE |
|
HI |
HIGH, INCREASED |
|
HW |
HEARTWORM(S) |
|
HX, H/O |
HISTORY OF |
|
IND |
INDIRECT; UNCONJUGATED |
|
INEFFECT |
LACK OF OR DECREASED EFFECTIVENESS |
|
INFECT |
INFECTION; INFECTED |
|
INFLAM |
INFLAMMATION; INFLAMED |
|
INJ |
INJECTION; INJECT |
|
INTEST |
INTESTINE |
|
IVF |
INTRAVENOUS FLUID |
|
K |
POTASSIUM |
|
KCS |
KERATOCONJUNCTIVITIS SICCA |
|
LAB |
LABWORK; RESULTS OF CHC/CHEMISTRIES/CULTURE RESULTS/ ULTRASOUND/RADIOGRAPHS |
|
LDH |
LACTIC DEHYDROGENASE |
|
LN |
LYMPH NODE(S) |
|
LO |
LOW; DECREASED |
|
LRS |
LACTATED RINGERS SOLUTION |
|
LYMPHS |
LYMPHOCYTES |
|
MG |
MAMMARY GLAND |
|
MGT |
MAMMARY GLAND TUMOR |
|
MF |
MICROFILARIA |
|
MONOS |
MONOCYTES |
|
MULT |
MULTIPLE |
|
NA |
SODIUM |
|
NEG |
NEGATIVE |
|
NSF |
NO SIGNIFICANT FINDINGS |
|
O/S |
ONSET |
|
P |
PHOSPHORUS |
|
PARENTERAL |
NOT VIA THE DIGESTIVE TRACT (INCLUDES INTRAMUSCULAR, INTRAVENOUS, AND SUBCUTANEOUS INJECTION) |
|
PD |
PRODUCT DEFECT |
|
PLATES |
PLATELETS |
|
PMNS |
SEGMENTED NEUTROPHILS |
|
PMP |
PREVIOUS MEDICAL PROBLEM |
|
POS |
POSITIVE |
|
PR |
PATHOLOGY REPORT; GROSS OR MICROSCOPIC PATHOLOGY INCLUDING CULTURE DATA (NEED NOT BE A FORMAL REPORT) |
|
PT |
PROTHROMBIN TIME |
|
PTT |
PARTIAL THROMBOPLASTIN TIME |
|
PTX |
PREVIOUS TREATMENT |
|
PX |
PROGNOSIS |
|
RAD(S) |
RADIOGRAPH(S) (X-RAYS) |
|
RBC |
RED BLOOD CELLS |
|
RECHAL |
THE EFFECT AFTER RE-INTRODUCING SUSPECT DRUG |
|
RECOV |
RECOVERY, RECOVERED |
|
REF |
REFERENCE |
|
RR |
NUMBER OF ANIMALS REACTING |
|
RESP |
RESPIRATORY |
|
RTX |
TREATMENT OF SUSPECTED ADVERSE DRUG REACTION |
|
RX |
TO PRESCRIBE/DISPENSE A PRESCRIPTION |
|
RXN |
REACTION |
|
SAP |
ALKALINE PHOSPHATASE |
|
SEGS |
SEGMENTED NEUTROPHILS |
|
SGOT/AST |
ASPARTITIE AMINOTRANSFERASE |
|
SGPT/ALT |
ALANINE AMINOTRANSFERASE |
|
SM |
SMALL |
|
SPEC |
SPECIFIC |
|
SG |
SPECIFIC GRAVITY OF FLUID (E.G. URINE) |
|
SQ |
SUBCUTANEOUS |
|
SQF |
SUBCUTANEOUS FLUID |
|
TD |
NUMBER OF ANIMALS TREATED |
|
TECH |
TECHNIQUE; TECHNICAL; TECHNICIAN |
|
TEMP |
TEMPORARAY |
|
TMP |
TREATED MEDICAL PROBLEM (REASON FOR USE OF SUSPECT DRUG) |
|
TOT |
TOTAL |
|
TOX |
TOXICITY; TOXIC |
|
TPR |
TEMPERATURE, PULSE, RESPIRATION |
|
TX |
TREATMENT |
|
UA |
URINALYSIS |
|
UDDER |
MAMMARY GLANDS OF ALL SPECIES |
|
US |
ULTRASOUND |
|
VACC |
VACCINE; VACCINATE |
|
VAX |
VACCINE; VACCINATE |
|
WBC |
WHITE BLOOD CELLS |
|
WD |
WITHDRAWAL TIME |
|
WNL |
WITHIN NORMAL LIMITS |
|
||||||
 |
||||||
|
||||||